COVID-19 has forced us to innovate with unparalleled urgency – what would happen if we channelled that energy into addressing climate change?
The world has breathed a collective sigh of relief. After nine months of waiting, vaccines are inbound. The recent announcements from Pfizer/BioNTech, Moderna and Oxford/AstraZeneca are the first signs that we may be able to get the pandemic under control and get back to normal. The speed at which these have been developed is unparalleled in medicinal history. The process has been innovative to its core and provides an excellent blueprint for us to take forward to address our next great challenge: the climate crisis.
Demand is high for solutions and business innovation is desperately needed to transform the global economy into a circular one to avoid a climate catastrophe. Most companies vocalise their support for sustainability, but it is not an R&D focus for the great majority, with 72 per cent allocating less than a quarter of their R&D budget to sustainability according to our International Innovation Barometer. More n
Exclusive member-only content 
